Normobaric oxygen
Normobaric oxygen has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Jan 14, 2026: “The Effect of Atmospheric Saturated Oxygen Combined With Intelligent Upper and Lower Limb Rehabilitation Training on Diabetic Lower Extremity Arterial Disease”.
1 paper studies it5 findingsUpdated
See all 1 papers on normobaric oxygen
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“VAS decreased more (3.82 ± 0.75 vs. 2.15 ± 0.62 points)”
None of its findings points the other way.
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave normobaric oxygen to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Improves pain3.82 ± 0.75 vs. 2.15 ± 0.62 points up: Improves physical function28.67 ± 4.21 vs. 15.33 ± 3.85 points down: Decreases blood glucoseFBG 2.35 ± 0.52 vs. 1.21 ± 0.45 mmol/L; 2hPBG 3.12 ± 0.68 vs. 1.78 ± 0.59 mmol/L | Randomized trial | 60 peopleIn patients with diabetic lower extremity arterial disease receiving rehabilitation training | Journal of diabetes research, Jan 14, 2026 |
What did studies of normobaric oxygen find?
5Studies of normobaric oxygen measured 5 outcomes, among them ankle-brachial index, inflammation and blood glucose.
Ankle-brachial index
upin humans1
1 study
Ankle-brachial index
upin humans1
Normobaric oxygen increases ankle-brachial index in humans (ABI 0.38 ± 0.07 vs. 0.20 ± 0.06).
“ABI (0.38 ± 0.07 vs. 0.20 ± 0.06), TcPO2 (18.67 ± 3.25 vs. 9.35 ± 2.78 mmHg), and DPA flow velocity (0.18 ± 0.04 vs. 0.09 ± 0.03 m/s) increased more”
Human trialin patients with diabetic lower extremity arterial disease receiving rehabilitation trainingn = 60
Journal of diabetes research
Inflammation
downin humans1
1 study
Inflammation
downin humans1
Normobaric oxygen inhibits inflammation in humans (IL-6 8.76 ± 1.52 vs. 4.23 ± 1.18 pg/mL; CRP 12.35 ± 2.18 vs. 6.12 ± 1.85 mg/L).
“IL-6 (8.76 ± 1.52 vs. 4.23 ± 1.18 pg/mL) and CRP (12.35 ± 2.18 vs. 6.12 ± 1.85 mg/L) decreased more”
Human trialin patients with diabetic lower extremity arterial disease receiving rehabilitation trainingn = 60
Journal of diabetes research
Blood glucose
downin humans1
1 study
Blood glucose
downin humans1
Normobaric oxygen decreases blood glucose in humans (FBG 2.35 ± 0.52 vs. 1.21 ± 0.45 mmol/L; 2hPBG 3.12 ± 0.68 vs. 1.78 ± 0.59 mmol/L).
“FBG (2.35 ± 0.52 vs. 1.21 ± 0.45 mmol/L) and 2hPBG (3.12 ± 0.68 vs. 1.78 ± 0.59 mmol/L) decreased more”
Human trialin patients with diabetic lower extremity arterial disease receiving rehabilitation trainingn = 60
Journal of diabetes research
Physical function
upin humans1
1 study
Physical function
upin humans1
Normobaric oxygen improves physical function in humans (28.67 ± 4.21 vs. 15.33 ± 3.85 points).
“Barthel index increased more (28.67 ± 4.21 vs. 15.33 ± 3.85 points)”
Human trialin patients with diabetic lower extremity arterial disease receiving rehabilitation trainingn = 60
Journal of diabetes research
Pain
upin humans1
1 study
Pain
upin humans1
Normobaric oxygen improves pain in humans (3.82 ± 0.75 vs. 2.15 ± 0.62 points).
“VAS decreased more (3.82 ± 0.75 vs. 2.15 ± 0.62 points)”
Human trialin patients with diabetic lower extremity arterial disease receiving rehabilitation trainingn = 60
Journal of diabetes research